Printer Friendly
The Free Library
14,537,783 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Anemia topic

Subtopics (26)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
Anemia Drug Ups Blood Clot Risk in Cancer Patients. Nov 13, 2009 160
Study raises concerns about anemia drugs. Oct 31, 2009 524
Affymax Provides Phase 3 Program Update for Investigational Drug, Hematide[TM], to Treat Anemia in Chronic Renal Failure. Sep 9, 2009 822
A child with fever, hepatosplenomegaly, weight loss and anemia/Ates, hepatosplenomegali, kilo kaybi ve anemisi olan bir cocuk. Isikay, Sedat; Buyukavci, Mustafa; Tan, Huseyin; Ulker, Dondu; Orbak, Zerrin Sep 1, 2009 1883
Clinical trial: a company-sponsored clinical study by Amgen Inc. found that its anemia drug Aranesp didn't improve heart conditions of patients with chronic kidney disease, but didn't hurt the patients either. Clinical report Aug 31, 2009 94
Medgenics, Inc. Announces Patient Nearing Unprecedented 11 Months of Anemia Relief in Clinical Trial From Single Treatment of Biopump Tissue Technology; News Follows Significant Interest of Strategic Partner for New Application. Aug 27, 2009 904
Acceleron and Celgene Initiate Phase 2 Study of ACE-011 to Treat Chemotherapy-Induced Anemia. Jul 28, 2009 725
Don't Forget the B12 When Using Folic Acid. Gaby, Alan R. Jul 1, 2009 338
Research and Markets: Latest News and Developments for the Anemia Drug Therapy Area Pipeline with Pipeline Status of Drugs by Company and by Stage. May 11, 2009 339
Thalassaemia- a form of anemia. May 8, 2009 162
Research and Markets: Renal Anemia: Early Diagnosis and Management of Anemia: Reducing Costs and Improving the Outcomes in Chronic Kidney Disease. May 7, 2009 396
Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients. Mar 27, 2009 866
Low selenium linked with increased anemia risk in elderly. Hunter, Kim Report Mar 22, 2009 361
Medgenics Announces Positive Data from Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease. Feb 3, 2009 1334
Patient Recruitment Resumes in FibroGen Phase 2 Study of Investigational Oral HIF-PH Inhibitor, FG-4592/ASP1517, for the Treatment of Anemia Associated with Chronic Kidney Disease. Report Jan 30, 2009 1921
Acceleron Introduces Breakthrough Program for Treatment of Anemia at the 27th Annual JP Morgan Healthcare Conference. Conference news Jan 13, 2009 516
Efficacy of cisplatin and vinorelbine in patients with metastatic non-small cell lung carcinoma/ Metastatik kucuk hucreli disi akciger karsinomlu hastalarda sisplatin ve vinorelbinin etkinligi. Yilmaz, Ufuk; Halilcolar, Huseyin; Yildirim, Yasemin; Yapicioglu, Sena; Unsal, Ipek; Mahlec, Ceyda Clinical report Dec 1, 2008 2750
Affymax Completes Enrollment in Phase 3 Program for Hematide in Chronic Renal Failure with Completion of Enrollment in EMERALD 2, the Final of Four Phase 3 Clinical Trials of Hematide(TM). Nov 17, 2008 835
Affymax Completes Enrollment in EMERALD 1, the Third of Four Phase 3 Clinical Trials of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients. Nov 13, 2008 816
Affymax Announces New Data Presented on the Long-Term Safety and Effectiveness of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients with Monthly Dosing. Nov 6, 2008 1023
United States: Affymax Completes Enrollment in Second Phase III Anemia Trial. Nov 5, 2008 348
Medgenics Announces Encouraging Preliminary Data for Phase I/II Clinical Trial of EPODURE in Renal Anemia. Nov 3, 2008 1250
Affymax Completes Enrollment in PEARL 2, the Second of Four Phase 3 Clinical Trials of Hematide to Treat Anemia in Chronic Renal Failure Patients. Nov 3, 2008 833
Suit won: A federal court upheld a prior jury decision affirming Amgen Inc.'s patents for anemia drugs Epogen and Aranesp, and ruled it is entitled to a permanent injunction against Swiss competitor Roche AG. Oct 13, 2008 96
Takeda and Affymax Provide Clinical Development Update for Hematide(TM) in Chemotherapy-Induced Anemia. Aug 28, 2008 554
Affymax Completes Enrollment in PEARL 1, the First of Four Phase 3 Clinical Trials of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients. Jul 9, 2008 875
Affymax Initiates Clinical Trial of Hematide(TM) to Evaluate Correction of Anemia in Chronic Renal Failure Patients on Dialysis. Correction notice Jun 30, 2008 670
Anemia drugs may speed growth of cancer. Jun 17, 2008 315
Anaemia of chronic diseases is a common condition. Bihl, Geoffrey Report May 1, 2008 1704
Primary drug-induced anaemia and the importance of adverse drug reaction (ADR) monitoring. Leisegang, Rory; Blockman, Marc Report May 1, 2008 1357
Anaemia. Jacobson, Barry Guest editorial May 1, 2008 370
Decrease in the hematocrit. Brief article May 1, 2008 189
Chemotherapy-induced anemia and risk of breast cancer recurrence. Washington, Meghan Brief article May 1, 2008 257
Affymax and Takeda Report Long-Term Safety and Effectiveness Data of Hematide in Chronic Renal Failure Patients With Anemia. Apr 4, 2008 714
Amgen to Discuss Benefits and Risks of ESA Treatment for Cancer Patients with Anemia Due to Chemotherapy at FDA ODAC Meeting. Mar 13, 2008 1892
Repros' IND for the Commencement of Phase III Studies of Proellex(R) in the Treatment of Anemia Associated with Uterine Fibroids is Now Effective. Feb 22, 2008 1125
VGX Pharmaceuticals Announces the IND Filing of VGX-3200, a Novel DNA Therapy That Utilizes GHRH for the Treatment of Cancer Cachexia and Anemia. Clinical report Feb 8, 2008 362
Agency receives new data for anemia drug risks. Jan 15, 2008 563
Nutritional imbalances in anemia. Werbach, Melvyn R. Jan 1, 2008 1765
NCCN Updates Cancer- and Treatment-Related Anemia Guidelines. Dec 20, 2007 665
My dark night. Baumel, Joan French Nov 23, 2007 820
Feds issue subpoenas for Amgen records; ''Documents related to products''; Not clear if data sought about anemia drugs. Nov 13, 2007 415
Affymax(R) Announces Hematide(TM) Successfully Restores Hemoglobin in Patients with Pure Red Cell Aplasia (PRCA). Nov 5, 2007 1316
Amgen wins patent case on Roche anemia drug. Oct 24, 2007 334
Repros Provides Update for Regulatory Program Associated with Proellex(R) Development for Uterine Fibroids and Anemia. Oct 17, 2007 717
Affymax Doses First Patient in the Phase 3 Clinical Program of Hematide(TM) to Treat Anemia in Chronic Renal Failure Patients. Oct 11, 2007 833
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee. Sep 11, 2007 1912
Heart failure: erythropoietin in treatment of anemia / Kalp yetersizligi: anemi tedavisinde eritropoetin. Buyuklu, Mutlu; Adresi, Yazisma Letter to the editor Sep 1, 2007 781
Amgen executive angered over coverage restrictions: CMS won't pay for anemia treatment, which means fewer Aranesp sales. Crowe, Deborah Aug 6, 2007 519
FDA, CMS to Look Closer at Anemia Drugs. Aug 1, 2007 325
Anemia Drug Developments Reviewed in Pipeline Report. Jul 16, 2007 364
VGX Pharmaceuticals Announces Issuance of Two Key U.S. Patents Covering DNA Plasmid Manufacturing Technology and the Treatment of Anemia. Jul 11, 2007 357
Routine use of anthelmintics can improve anaemia. Farham, Bridget Brief article Jul 1, 2007 260
Affymax(R) Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide(TM) for the Treatment of Anemia. Clinical report Jun 25, 2007 673
Better assessment of transfusions could save blood. Brief article Jun 1, 2007 189
Anemia treatment warnings. Jun 1, 2007 324
The separate--but overlapping--root causes of anemia. Jun 1, 2007 712
Astellas Pharma says patient died in anemia drug trial. Brief article May 21, 2007 131
Roche Receives Approvable Letter for MIRCERA(R) in the United States. May 18, 2007 888
Affymax(R) Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide(TM) for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease. Apr 23, 2007 660
Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide(TM) for the Treatment of Anemia in Dialysis Patients. Apr 12, 2007 648
FDA strengthens safety information for ESAs. Mar 12, 2007 424
NCCN Updates Cancer- and Treatment-Related Anemia Guidelines. Clinical report Mar 5, 2007 564
Elevated red cell distribution width in the diagnosis of thrombotic thrombocytopenic purpura in patients presenting with anemia and thrombocytopenia. Braverman, Albert Mar 1, 2007 1878
Pernicious anemia. Kumar, Vijay Feb 1, 2007 1254
Amgen shares decline over drug concerns; Risks to cancer patients found; Study of anemia drug Aranesp. Jan 27, 2007 535
Final Phase 2 Data Continue to Show Promising Results after One Year of Aranesp(R) Treatment for Anemia in Patients with Myelodysplastic Syndromes (MDS). Disease/Disorder overview Dec 10, 2006 1885
New Phase 2 Data Show Promise of Aranesp(R) Treatment for Anemia of Cancer. Dec 9, 2006 1881
Data Show Efficacy of Extended Dosing of Aranesp(R) in the Treatment of Chemotherapy-Induced Anemia. Dec 9, 2006 2324
Amgen Responds to Reports About Use and Safety of EPOGEN and Aranesp in CKD Anemia Therapy. Dec 5, 2006 412
Amgen Receives Complete Response Letter for Extended Dosing of Aranesp(R) for Patients with Chronic Kidney Disease and Anemia. Oct 13, 2006 1615
Amgen Launches Aranesp(R) (Darbepoetin Alfa) Prefilled SureClick(TM) Autoinjector for Treatment of Anemia Associated with Chemotherapy and Chronic Kidney Disease. Sep 7, 2006 2134
Nektar Announces Receipt of $17.6 Million Payment From Affymax, Inc. Under Agreement for Nektar Advanced PEGylation Technology; Cash Payment Resulting From Affymax and Takeda Signing Global Agreement for Hematide(TM) for the Treatment of Anemia. Jul 24, 2006 613
AMGEN PROFITS ENJOY NEW ZIP ANEMIA DRUG ADDS VIGOR TO EARNINGS. Jul 21, 2006 395
Final Results of Phase 2 Clinical Trial Program Suggest Treatment of Anemia with Aranesp(R) (Darbepoetin Alfa) May Decrease Risk of Hospitalization and All-Cause Mortality in Heart Failure Patients with Anemia, Based on a Prespecified Pooled Analysis. Jun 19, 2006 2235
Horse Racing: Owners put on alert as two cases of Equine Infectious Anaemia emerge. Jun 18, 2006 282
Blood, iron, and gray hair: anemia in old age is a rising concern. Harder, Ben Jun 3, 2006 2215
Large Head-to-Head Study of Aranesp(R) Dosed Every Two Weeks versus Epoetin Alfa Dosed Weekly Published in the Journal of Clinical Oncology. May 18, 2006 1924
NCCN Announces Important Updates to Cancer- and Treatment-Related Anemia Guidelines. May 10, 2006 630
Albion Advanced Nutrition: mastering minerals research. Wright, Rebecca May 1, 2006 682
FibroGen Licenses Oral HIF-PH Inhibitors, Including FG-2216 and FG-4592, to Astellas for the Treatment of Anemia in Europe and Other Regions; FibroGen Positioned to Develop First Oral Anemia Therapy for North America. Apr 28, 2006 831
FDA Approves Extended Dosing of Aranesp(R) to Treat Chemotherapy-Induced Anemia; Every-Three-Week Dosing Can Provide Added Convenience, Potentially Reducing Number of Clinic Visits and Injections for Anemia Treatment. Mar 27, 2006 1913
Block on anaemia drug attacked. Mar 18, 2006 157
New Phase 2 Data Suggest Treatment of Anemia with Aranesp(R) (Darbepoetin Alfa) May Provide Clinical Benefits in Heart Failure Patients. Mar 13, 2006 2067
ProMetic Receives Authorization From Health Canada to Initiate Phase IB/II Clinical Trial for Anemia Drug PBI-1402, Mechanism of Action of PBI-1402 Revealed. Feb 13, 2006 618
Scientists Report Intermittent, Oral Dosing of the HIF-PH Inhibitor, FG-2216, Increases and Maintains Hemoglobin Levels in a Preclinical Study of Chronic Anemia. Dec 13, 2005 693
New Phase 3 Data Show Potential Benefits of Aranesp(R) Dosed Every Three Weeks for Chemotherapy-Induced Anemia; Aranesp Treatment Achieved and Maintained Target Hemoglobin Levels and Reduced Incidence of Red Blood Cell Transfusions. Dec 12, 2005 1744
Updated Interim Aranesp(R) Phase 2 Data Suggest Major Response in Anemic Patients with Myelodysplastic Syndrome (MDS); Patients with Bone Marrow Disorder Also Showed Improvements in Hemoglobin Levels and Fatigue. Dec 11, 2005 1776
Quinupristin--dalfopristin-induced reticulocytopenic anemia. Mehta, Sanjay Dec 1, 2005 760
FibroGen Provides Update on the Development of FG-2216 and FG-4592, Oral Therapies for Anemia. Nov 14, 2005 1359
Data Show Aranesp(R) (Darbepoetin Alfa) Administered Once Monthly Maintains Hemoglobin Levels in Chronic Kidney Disease Patients with Anemia. Nov 12, 2005 1830
The effect of Juzen-taiho-to/TJ-48 on the expression of killer-cell immunoglobulin-like receptors (CD158a/b) on peripheral lymphocytes in vitro experiment. Kogure, T.; Ltoh, K.; Tatsumi, T.; Sekiya, N.; Sakai, S.; Shimada, Y.; Tamura, J.; Terasawa, K. May 1, 2005 2866
Amgen trial will evaluate impact of treating anemia on cardiovascular risks in patients with CKD, type 2 diabetes. Brief Article Nov 16, 2004 296
Double credit: iron-fortified salt cuts anemia. Harder, B. Oct 30, 2004 421
Iron needs before and after menopause. Osher, Susan Sep 1, 2004 696
Pernicious anemia: presentations mimicking acute leukemia. Page, Ray Mar 1, 2004 1656
Age-related anemia hastens death. Brief Article Jan 10, 2004 178
Failure to address post-partum anaemia in Uganda. Brief Article Nov 1, 2003 208
Anemia tied to physical decline in the elderly: independent lifestyles at risk. Sullivan, Michele G. Sep 1, 2003 578
Anaemia due to pregnancy and HIV = risk of early post-natal death, Harare. Berer, Marge Nov 1, 2002 339

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles